DiaMedica Therapeutics Inc. (OTCMKTS:DMCAF)’s stock price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $3.88 and last traded at $3.87, with a volume of 155988 shares trading hands. The stock had previously closed at $3.63.
The company has a 50 day simple moving average of $3.76 and a 200-day simple moving average of $6.71.
DiaMedica Therapeutics Company Profile (OTCMKTS:DMCAF)
DiaMedica Therapeutics Inc, a clinical-stage biopharmaceutical company, engages in the development of treatments for neurological and kidney diseases. The company's lead product is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase II clinical trials for the treatment of acute ischemic stroke and kidney injury indications.
Featured Story: Is it Safe to Invest in Commodities?
Receive News & Ratings for DiaMedica Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaMedica Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.